MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202647092179 A) filed by Pulse Pharmaceuticals Pvt Ltd on July 29, 2026, for A Stable Oral Pro-Dispersion Formulation And Implementations Thereof.
Inventors include Parvathabhatla, Naga Hemanth Kumar; Devaraj, Gopinath; Devraj, Rambhau; and Chintabhatla, Krishna Kaushik.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present disclosure provides a stable oral pro-dispersion formulation, comprising (i) an active pharmaceutical ingredient (API); (ii) a specialised polymeric interfacial modifier (SPIM); (iii) a lipid; (iv) a surfactant; and (v) a solvent, and a method of preparation thereof. The present disclosure further provides a capsule comprising the pro-dispersion formulation, a method of preparation thereof, and a method of treatment of a condition using the formulation or the capsule.
Disclaimer: Curated by HT Syndication.
